comparemela.com

Latest Breaking News On - Michaelg kauffman - Page 1 : comparemela.com

KPTI Stock Price | Karyopharm Therapeutics Inc Stock Quote (U S : Nasdaq)

SIRTLab Corporation Appoints Michael G Kauffman, MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer

SIRTLab Corporation Appoints Michael G Kauffman, MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer

Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress

Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer

Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer Richard Paulson, Recent Chief Executive Officer of Ipsen North America and Former Vice President and General Manager of Oncology at Amgen, Brings Wealth of Commercial Leadership and Global Strategic Experience Michael G. Kauffman to Remain on Board of Directors and Assume New Role as Senior Clinical Advisor News provided by Share this article Share this article NEWTON, Mass., May 3, 2021 /PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Richard Paulson as Karyopharm s President and Chief Executive Officer, effective May 3, 2021. Mr. Paulson will also remain a member of the Board of Directors. He will succeed Michael G. Kauffman, MD, PhD, as Chief Executive Officer and Sharon Shacham, PhD, MBA, as President. Dr. Kauffman will continue in his role as a member

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.